What is ‘scromiting’? US citizens warned about terrifying cannabis side effect

On October 1, 2025, the World Health Organization officially assigned a diagnostic code to Cannabis Hyperemesis Syndrome. This step, though administrative on the surface, is important for public health tracking and clinical research.

Dr. Carlini explains that having a formal diagnostic code helps physicians document cases more consistently. Over time, this standardized reporting provides researchers with real-world data about trends, severity, and risk factors. It also facilitates better communication between hospitals and public health agencies.

Treatment and Long-Term Outlook
In the short term, CHS requires medical attention when symptoms become severe, particularly if dehydration or electrolyte imbalances occur. Emergency departments can provide fluids, medications, and monitoring to stabilize patients.

However, doctors emphasize that the only proven long-term solution is reducing or discontinuing cannabis use. Once cannabis is removed from an individual’s routine, CHS symptoms usually stop. But if cannabis use resumes, symptoms often return.

For some people, this presents challenges related to dependence, especially if they have been using cannabis to manage stress, anxiety, or chronic discomfort. In these cases, clinicians may recommend counseling, support groups, or alternative therapies.

Why Increased Awareness Matters
Because CHS is still unfamiliar to many people, individuals often delay seeking care or are treated repeatedly without receiving clear guidance. Those experiencing recurring symptoms may attribute them to diet, stress, or unrelated stomach issues. Without awareness of CHS, individuals who use cannabis may not consider it a contributing factor.

Greater public education helps: